rachel evans
King's College London
London, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
King's College London
London, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Duke-NUS Medical School
Singapore, Singapore
Review Editor
Cancer Immunity and Immunotherapy
European Institute of Oncology (IEO)
Milan, Italy
Review Editor
Cancer Immunity and Immunotherapy
University of A Coruña
A Coruña, Spain
Review Editor
Cancer Immunity and Immunotherapy
Australian National University
Canberra, Australia
Review Editor
Cancer Immunity and Immunotherapy
University of Oxford
Oxford, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Hannover Medical School
Hanover, Germany
Review Editor
Cancer Immunity and Immunotherapy
University of Perugia
Perugia, Italy
Review Editor
Cancer Immunity and Immunotherapy
Semmelweis University
Budapest, Hungary
Review Editor
Cancer Immunity and Immunotherapy
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Review Editor
Cancer Immunity and Immunotherapy
Department of Oncology and Department of Biomedical and Clinical Sciences, Linköping University,
Linkoping, Sweden
Review Editor
Cancer Immunity and Immunotherapy
School of Pharmacy, Fudan University
Shanghai, China
Review Editor
Cancer Immunity and Immunotherapy
Scientific Institute of Romagna for the Study and Treatment of Tumors (IRCCS)
Meldola, Italy
Review Editor
Cancer Immunity and Immunotherapy
Xilio Therapeutics, Inc.
Waltham, United States
Review Editor
Cancer Immunity and Immunotherapy
Institute for Tumor Biology and Experimental Therapy, Georg Speyer Haus
Frankfurt, Germany
Review Editor
Cancer Immunity and Immunotherapy
University of Padua
Padua, Italy
Review Editor
Cancer Immunity and Immunotherapy